[go: up one dir, main page]

GB0621205D0 - Inhibitors of PLK - Google Patents

Inhibitors of PLK

Info

Publication number
GB0621205D0
GB0621205D0 GB0621205A GB0621205A GB0621205D0 GB 0621205 D0 GB0621205 D0 GB 0621205D0 GB 0621205 A GB0621205 A GB 0621205A GB 0621205 A GB0621205 A GB 0621205A GB 0621205 D0 GB0621205 D0 GB 0621205D0
Authority
GB
United Kingdom
Prior art keywords
plk
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0621205A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chroma Therapeutics Ltd
Original Assignee
Chroma Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chroma Therapeutics Ltd filed Critical Chroma Therapeutics Ltd
Priority to GB0621205A priority Critical patent/GB0621205D0/en
Publication of GB0621205D0 publication Critical patent/GB0621205D0/en
Priority to AU2007310604A priority patent/AU2007310604B2/en
Priority to CNA2007800399378A priority patent/CN101541800A/en
Priority to JP2009533934A priority patent/JP2010507639A/en
Priority to AT07824247T priority patent/ATE542820T1/en
Priority to EA200900593A priority patent/EA200900593A1/en
Priority to PCT/GB2007/003998 priority patent/WO2008050096A1/en
Priority to MX2009004244A priority patent/MX2009004244A/en
Priority to CA002665736A priority patent/CA2665736A1/en
Priority to US12/446,008 priority patent/US20100216802A1/en
Priority to BRPI0718120-5A priority patent/BRPI0718120A2/en
Priority to NZ577153A priority patent/NZ577153A/en
Priority to KR1020097010620A priority patent/KR20090071668A/en
Priority to EP07824247A priority patent/EP2079743B1/en
Priority to IL198082A priority patent/IL198082A0/en
Priority to ZA200902730A priority patent/ZA200902730B/en
Ceased legal-status Critical Current

Links

GB0621205A 2006-10-25 2006-10-25 Inhibitors of PLK Ceased GB0621205D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB0621205A GB0621205D0 (en) 2006-10-25 2006-10-25 Inhibitors of PLK
EP07824247A EP2079743B1 (en) 2006-10-25 2007-10-19 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
PCT/GB2007/003998 WO2008050096A1 (en) 2006-10-25 2007-10-19 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
CA002665736A CA2665736A1 (en) 2006-10-25 2007-10-19 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
JP2009533934A JP2010507639A (en) 2006-10-25 2007-10-19 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
AT07824247T ATE542820T1 (en) 2006-10-25 2007-10-19 PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS FOR THE TREATMENT OF CANCER
EA200900593A EA200900593A1 (en) 2006-10-25 2007-10-19 DERIVATIVES DERIVATIVES AS AN INHIBITORS OF POLO-SIMILAR KINASE APPLIED IN THE TREATMENT OF CANCER
AU2007310604A AU2007310604B2 (en) 2006-10-25 2007-10-19 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
MX2009004244A MX2009004244A (en) 2006-10-25 2007-10-19 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer.
CNA2007800399378A CN101541800A (en) 2006-10-25 2007-10-19 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
US12/446,008 US20100216802A1 (en) 2006-10-25 2007-10-19 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
BRPI0718120-5A BRPI0718120A2 (en) 2006-10-25 2007-10-19 PTERIDINE DERIVATIVES AS POLE TYPE KINASE INHIBITORS USEFUL IN CANCER TREATMENT
NZ577153A NZ577153A (en) 2006-10-25 2007-10-19 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
KR1020097010620A KR20090071668A (en) 2006-10-25 2007-10-19 Pteridine Derivatives as Polo Kinase Inhibitors Useful in Cancer Therapy
IL198082A IL198082A0 (en) 2006-10-25 2009-04-07 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
ZA200902730A ZA200902730B (en) 2006-10-25 2009-04-20 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0621205A GB0621205D0 (en) 2006-10-25 2006-10-25 Inhibitors of PLK

Publications (1)

Publication Number Publication Date
GB0621205D0 true GB0621205D0 (en) 2006-12-06

Family

ID=37545941

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0621205A Ceased GB0621205D0 (en) 2006-10-25 2006-10-25 Inhibitors of PLK

Country Status (3)

Country Link
CN (1) CN101541800A (en)
GB (1) GB0621205D0 (en)
ZA (1) ZA200902730B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102190669A (en) * 2010-03-19 2011-09-21 江苏恒瑞医药股份有限公司 Dihydro pteridinone derivatives, preparation method thereof and application thereof in medicines
CN103435608A (en) * 2013-08-22 2013-12-11 中国药科大学 Pyridino-miazines PLK1 (Polo-like kinase 1) inhibitor and application thereof
CN105801582A (en) * 2016-04-12 2016-07-27 合肥工业大学 Novel dihydro pteridinone derivative, preparing method thereof and application to medicine
CN109879877B (en) * 2019-03-04 2021-08-10 吉林大学 Compound capable of degrading PLK1 and BRD4 proteins and application thereof
CN113717941B (en) * 2020-05-26 2023-11-14 中科院合肥技术创新工程院 A culture medium, culture method and application for laryngeal cancer epithelial cells

Also Published As

Publication number Publication date
CN101541800A (en) 2009-09-23
ZA200902730B (en) 2010-03-31

Similar Documents

Publication Publication Date Title
HUS2200052I1 (en) Imidazotriazines and imidazopyrimidines as kinase inhibitors
ZA200808282B (en) Uses of DPP-IV inhibitors
PT2402319T (en) Dgat inhibitors
PL2361922T3 (en) Intermediate to HCV-Nucleoside Inhibitors
ZA201000318B (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
GB0621203D0 (en) PLK inhibitors
EP2026843A4 (en) Therapeutic uses of inhibitors of rtp801l
ZA200809873B (en) Inhibitors of c-fms kinase
GB0621607D0 (en) Inhibitors of c-Met
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
GB0807451D0 (en) Inhibitors of PLK
GB0621205D0 (en) Inhibitors of PLK
IL197981A0 (en) Kinase inhibitors
GB0807452D0 (en) PLK inhibitors
GB0715614D0 (en) Inhibitors of plk
IL198149A0 (en) Novel inhibitors of chymase
GB0608822D0 (en) Inhibitors of DHFR
GB0621283D0 (en) Inhibitors of PLK Enzymes
GB0621282D0 (en) PLK enzyme inhibitors
GB0621103D0 (en) Inhibitors of MEK
GB0621107D0 (en) Inhibitors of phosphodiesterase-4
GB0621980D0 (en) Inhibitors of c-Met
GB0622367D0 (en) Phosphodiesterase inhibitors
IL195722A0 (en) Therapeutic uses of inhibitors of rtp801l

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)